ウェスタンブロッティング（WB）の世界市場予測：装置、消耗品...市場調査レポートについてご紹介

1 Introduction (Page No. – 17)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology (Page No. – 20)
2.1 Research Methodology Steps
2.2 Secondary and Primary Research Methodology
2.2.1 Secondary Research
2.2.1.1 Key Data From Secondary Sources
2.2.2 Primary Research
2.2.2.1 Key Data From Primary Sources
2.2.2.2 Key Insights From Primary Sources
2.2.2.3 Key Industry Insights
2.3 Market Size Estimation Methodology
2.4 Market Data Validation and Triangulation
2.5 Assumptions for the Study

3 Executive Summary (Page No. – 30)
3.1 Introduction
3.2 Conclusion

4 Premium Insights (Page No. – 34)
4.1 Western Blotting: Market Overview
4.2 Geographic Analysis: Western Blotting Market, By End User
4.3 Market, By Product
4.4 Market, By Application
4.5 Market, By End User
4.6 Geographic Snapshot: Western Blotting Market

5 Market Overview (Page No. – 38)
5.1 Introduction
5.1.1 Market Drivers
5.1.1.1 Increasing Research Activities and R&D Spending By Pharmaceutical and Biotechnology Companies
5.1.1.2 Rising Prevalence of HIV/Aids
5.1.1.3 Growing Proteomics Market
5.1.1.4 Growing Number of Industry-Academic Research Collaborations
5.1.1.5 Increasing Demand for Personalized Medicine
5.1.1.6 New Product Launches
5.1.2 Market Restraints
5.1.2.1 Emergence of Alternative Technologies
5.1.3 Market Opportunities
5.1.3.1 Automation in Western Blotting Instruments
5.1.3.2 Emerging Economies to Offer Significant Growth Opportunities for the Western Blotting Market
5.1.4 Market Challenges
5.1.4.1 Requirement of High Procedural Efficiency for Accurate Results
5.1.4.2 Stringent Regulations

6 Global Western Blotting Market, By Product (Page No. – 46)
6.1 Introduction
6.2 Consumables
6.2.1 Reagents
6.2.2 Kits
6.2.3 Other Consumables
6.3 Instruments
6.3.1 Gel Electrophoresis Instruments
6.3.2 Blotting Systems
6.3.2.1 Wet Blotting Systems
6.3.2.2 Semi-Dry Blotting Systems
6.3.3 Imagers
6.3.3.1 Chemiluminescent Imagers
6.3.3.2 Fluorescent Imagers
6.3.3.3 Other Imagers

7 Western Blotting Market, By Application (Page No. – 64)
7.1 Introduction
7.2 Biochemical & Biomedical Research
7.3 Disease Diagnostics
7.4 Agriculture
7.5 Other Applications

8 Western Blotting Market, By End User (Page No. – 70)
8.1 Introduction
8.2 Academic and Research Institutes
8.3 Pharmaceutical and Biotechnology Companies
8.4 Diagnostic Laboratories
8.5 Other End Users

9 Western Blotting Market, By Region (Page No. – 76)
9.1 Introduction
9.2 North America
9.2.1 U.S.
9.2.1.1 Increasing Prevalence of HIV and Lyme Disease
9.2.1.2 U.S.-China Collaborative Program for Biomedical Research
9.2.1.3 Rise in Research Funding and Increasing Production of Genetically Modified Crops
9.2.1.4 Conferences, Meetings, and Symposiums
9.2.2 Canada
9.2.2.1 HIV Vaccine Initiative
9.2.2.2 Growing Intensity of Pharmaceutical and Biopharmaceutical Clinical Research
9.3 Europe
9.3.1 Europe-5
9.3.1.1 Strong Academic and Research Base in Germany
9.3.1.2 Availability of Research Funding in the U.K.
9.3.1.3 Growth in the Spanish Biotechnology Industry
9.3.2 RoE
9.3.2.1 High Presence of Pharmaceutical and Biotechnology Companies
9.3.2.2 Conferences, Workshops, and Congresses on Western Blotting Application Areas
9.4 Asia-Pacific
9.4.1 China
9.4.1.1 Increasing Government Interest in Biomedical and Biotechnology Industry
9.4.1.2 Presence of Bioclusters in China
9.4.1.3 Outsourcing of Clinical Research Activity to China
9.4.2 Japan
9.4.2.1 Government Initiatives Supported By Funding
9.4.2.2 Growing Pharmaceutical and Biotechnology Industry in Japan
9.4.3 India
9.4.3.1 Growing Pharmaceutical Industry in India, Backed By Government Initiatives
9.4.3.2 Development of Bioclusters
9.4.3.3 Growing Funding for Agriculture Research in India
9.4.4 RoAPAC
9.4.4.1 Korea-U.S. Free Trade Agreement (Korus)
9.4.4.2 Increasing Diagnosis of HIV and Related Funding in Australia
9.4.4.3 Growing Prevalence of Herpes Simplex Virus in Southeast Asia
9.5 RoW
9.5.1 Rising Prevalence of HIV in the Middle East and Africa
9.5.2 Increasing Focus of Pharmaceutical Companies on Africa
9.5.3 Presence of Large End-User Base in Brazil

10 Competitive Landscape (Page No. – 126)
10.1 Overview
10.2 Market Share Analysis
10.2.1 Introduction
10.2.2 Bio-Rad Laboratories, Inc. (U.S.)
10.2.3 Thermo Fisher Scientific, Inc. (U.S.)
10.2.4 GE Healthcare (U.S.)
10.3 Competitive Situation and Trends
10.3.1 Product Launches
10.3.2 Acquisitions
10.3.3 Agreements, Partnerships, and Collaborations
10.3.4 Expansions
10.3.5 Others

11 Company Profiles (Page No. – 135)
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
11.1 Introduction
11.2 Bio-Rad Laboratories, Inc.
11.3 Thermo Fisher Scientific, Inc.
11.4 GE Healthcare
11.5 Advansta Inc.
11.6 Li-Cor Biosciences
11.7 Perkinelmer, Inc.
11.8 Bio-Techne Corporation
11.9 F. Hoffmann-La Roche Ltd.
11.10 Merck Kgaa
11.11 Cell Signaling Technology

*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.

12 Appendix (Page No. – 160)
12.1 Discussion Guide
12.2 Other Developments
12.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
12.4 Introducing RT: Real-Time Market Intelligence
12.4.1 Features and Benefits of Rt:
12.5 Available Customization
12.5.1 Portfolio Analysis
12.5.2 Company Information
12.6 Related Reports
12.7 Author Details